6 Combat HIV/AIDS, malaria and other diseases

Where we are?

Overall progress and challenges on Pakistan’s MDGs

Pakistan has adopted 16 targets and 41 indicators against which progress towards achieving the Eight Goals of the MDG’s is measured. Time series data available for 33 of these indicators reveal that Pakistan is on track to achieve the targets on 9 indicators, whereas its progress on 24 indicators is off track.


In light of MDG 6, as the prevalence of HIV among the population has been historically low, Pakistan has surpassed the target for reducing HIV prevalence among 15-24 year old pregnant women and vulnerable groups. Progress in the proportion of TB cases detected and cured with ORS, an indicator for MDG 6, is on track with Pakistan expected to achieve its target for 2015.

In MDG 6, while targets are likely to be met in most indicators, Pakistan’s performance lags considerably in the proportion of population in malaria risk areas using malaria prevention and treatment measures and incidence of tuberculosis per 1,000,000 population. Both malaria and TB are contagious diseases and factors such as living conditions and inadequate provisions of medical care contribute to the current status on these indicators.

UNDP's work in Pakistan

  • Community members constructing a water course in Khyber Pakhtunkhwa province. Photo: UNDP Pakistan.

    Strengthening Village Communities through Seed Funding

    “The only source of our income is from cultivation and because of the damaged irrigation channel it was hard to live even and fulfill our basicmore

Targets for MDG6
  1. Halt and begin to reverse the spread of HIV/AIDS
    • HIV prevalence among population aged 15-24 years
    • Condom use at last high-risk sex
    • Proportion of population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS
    • Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years
  2. Achieve, by 2010, universal access to treatment for HIV/AIDS for all those who need it
    • Proportion of population with advanced HIV infection with access to antiretroviral drugs